A business in context
KYMR research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 3716.0 | 125.82 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 1609.0 | 126.71 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 25075.0 | 127.37 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 2197.0 | 128.69 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 337.0 | 129.61 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 5144.0 | 119.71 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 15660.0 | 120.66 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 5689.0 | 121.38 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 698.0 | 122.67 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 1517.0 | 123.62 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 1639.0 | 124.61 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 522.0 | 125.82 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 223.0 | 126.71 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 3507.0 | 127.37 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 265.0 | 110.3 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 86.0 | 110.79 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 2011.0 | 108.83 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 23.0 | 108.02 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 1399.0 | 107.3 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 19089.0 | 118.6 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 24268.0 | 117.5 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 81500.0 | 116.53 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 58205.0 | 115.57 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 9229.0 | 114.65 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 10215.0 | 113.7 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 719.0 | 111.89 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 614.0 | 110.79 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 1915.0 | 110.3 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 14351.0 | 108.83 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 100.0 | 111.89 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 1437.0 | 113.7 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 1289.0 | 114.65 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 8389.0 | 115.57 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 11375.0 | 116.53 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 3359.0 | 117.5 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 2646.0 | 118.6 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 9994.0 | 107.3 |
| 2026-06-25 | Booth Bruce | S · Sale | Common Stock | 159.0 | 108.02 |
| 2026-06-25 | Goodman Noah | S · Sale | Common Stock | 2500.0 | 119.0 |
| 2026-06-25 | Goodman Noah | S · Sale | Common Stock | 2500.0 | 109.0 |
| 2026-06-25 | Goodman Noah | M · Exercise / conversion | Common Stock | 5000.0 | 21.05 |
| 2026-06-25 | Goodman Noah | M · Exercise / conversion | Stock Option (Right to Buy) | 5000.0 | 0.0 |
| 2026-06-24 | Booth Bruce | S · Sale | Common Stock | 103688.0 | 100.42 |
| 2026-06-24 | Booth Bruce | S · Sale | Common Stock | 14513.0 | 100.42 |
| 2026-06-24 | Booth Bruce | S · Sale | Common Stock | 14490.0 | 101.14 |
| 2026-06-24 | Booth Bruce | S · Sale | Common Stock | 2029.0 | 101.14 |
| 2026-06-24 | Booth Bruce | A · Grant / award | Stock Option (Right to Buy) | 6068.0 | 0.0 |
| 2026-06-24 | Hrustanovic Gorjan | A · Grant / award | Stock Option (Right to Buy) | 6068.0 | 0.0 |
| 2026-06-24 | Ridloff Elena | A · Grant / award | Stock Option (Right to Buy) | 6068.0 | 0.0 |
| 2026-06-24 | MARAGANORE JOHN | A · Grant / award | Stock Option (Right to Buy) | 6068.0 | 0.0 |
Identity & relationships
SEC issuer · 0001815442Kymera Therapeutics, Inc.
Search names and former names
View Wikidata identity and references ↗
- Kymera Therapeutics · alias · wikidata
- Kymera Therapeutics, Inc. · former SEC name · 2020-06-22 to 2026-09-04
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $47.07M | $50.11M |
| 2023-12-31 | $78.59M | $86.12M |
| 2022-12-31 | $46.83M | $53.42M |
| 2021-12-31 | $72.83M | $89.74M |
| 2020-12-31 | $34.03M | $43.91M |
| 2019-12-31 | $2.93M | $3.83M |